Choolip & Sciences KRX:291650KOSDAQ
압타머사이언스 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, Choolip & Sciences reported revenue of ₩2.4bn, up 291.5% year on year, and an operating loss of ₩3.1bn. Choolip & Sciences (압타머사이언스) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals 4 quarters of losses Screener
Choolip & Sciences quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩2.4bn | +291.5% | −₩3.1bn margin −128.9% | −₩4.3bn |
| Q1 2026 | ₩707m | +19.0% | −₩1.5bn margin −210.4% | −₩2.4bn |
| Q4 2025 derived | ₩1.8bn | +90.8% | −₩1.9bn margin −110.7% | −₩3.0bn |
| Q3 2025 | ₩544m | +493.9% | −₩2.1bn | −₩2.0bn |
| Q2 2025 | ₩611m | +3001.4% | −₩1.5bn margin −253.6% | −₩1.4bn |
| Q1 2025 | ₩594m | +1056.6% | −₩2.2bn | −₩2.2bn |
| Q4 2024 derived | ₩920m | +644.3% | −₩1.9bn margin −210.8% | −₩1.6bn |
| Q3 2024 | ₩92m | +455.2% | −₩1.5bn | −₩1.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Choolip & Sciences top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Choolip & Sciences news Korean headlines
No articles yet.